GlassScriptPhysician profile
Casey Krug
NPI 1801565262
$3,442.60
in general payments reported to CMS, 2019-2025
17 companies · $1,432 in 2025
The $1,432 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.24 · 2022: $205 · 2023: $821 · 2024: $973 · 2025: $1,432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,534 · Education: $600 · Entertainment: $92.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,533.85 |
| Education | $600.00 |
| Entertainment | $92.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Notal Vision, INC. | $635.00 | 2025 | Foresee Home |
| Coopervision INC. | $515.77 | 2022-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $489.14 | 2022-2025 | Miebo, Xiidra, Infuse |
| Sun Pharmaceutical Industries INC. | $305.63 | 2023-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $292.24 | 2024 | Xdemvy |
| Alcon Vision LLC | $283.63 | 2023-2025 | Precision 1, Precision7, Total30 |
| Harrow Eye, LLC | $210.02 | 2024-2025 | Vevye |
| Lkc Technologies, INC. | $183.24 | 2023-2025 | |
| Abbvie INC. | $125.56 | 2023 | |
| Topcon Healthcare, INC. | $107.12 | 2024 | |
| Allergan, INC. | $98.48 | 2022 | |
| Optos, INC. | $92.72 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $27.69 | 2025 | Photrexa Viscous and Photrexa |
| Thea Pharma INC. | $23.55 | 2023 | |
| Biotissue Holdings INC. | $21.29 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.28 | 2023 | |
| Spark Therapeutics, INC. | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Krug listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.